| Dr David B Wait, MD | |
|
803 S Main St Ste 210, Moscow, ID 83843 | |
| (208) 883-6774 | |
| (208) 883-8155 |
| Full Name | Dr David B Wait |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 803 S Main St Ste 210, Moscow, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245306760 | NPI | - | NPPES |
| 806365900 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | M8523 (Idaho) | Primary |
| Entity Name | Harbor Youth And Family Counseling |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205466265 PECOS PAC ID: 7012338981 Enrollment ID: O20200601002016 |
News Archive
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
With a growing aging population in South Florida, a University of Miami geographer who specializes in public health teamed up with geriatricians and other geographers to conduct the first age-adjusted analysis of socially and medically vulnerable older adults in Miami-Dade, Broward, and Palm Beach counties.
Epigenomics AG , the cancer diagnostics company, and Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced that they have extended their licensing agreement for the prostate cancer biomarker GSTP1, originally signed in April 2009.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David B Wait, MD 700 S Main St, Moscow, ID 83843-3046 Ph: (208) 882-4511 | Dr David B Wait, MD 803 S Main St Ste 210, Moscow, ID 83843 Ph: (208) 883-6774 |
News Archive
"Between 1970 and 2010, most emerging countries achieved impressive gains in contraceptive coverage," but, "[b]y contrast, many sub-Saharan African (SSA) countries ... have started their contraceptive revolution very late and progress to date has been minimal," John May, a visiting fellow at the Center for Global Development (CGD), and Jean-Pierre Guengant, researcher emeritus at the Research Institute for Development (IRD) in Marseille, France, write in CGD's "Global Health Policy" blog.
With a growing aging population in South Florida, a University of Miami geographer who specializes in public health teamed up with geriatricians and other geographers to conduct the first age-adjusted analysis of socially and medically vulnerable older adults in Miami-Dade, Broward, and Palm Beach counties.
Epigenomics AG , the cancer diagnostics company, and Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced that they have extended their licensing agreement for the prostate cancer biomarker GSTP1, originally signed in April 2009.
Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.
› Verified 3 days ago
Rachel Ensley, PA-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 803 S Main St Ste 110, Moscow, ID 83843 Phone: 208-813-7519 Fax: 208-813-7524 | |
Dr. Luke Billmeyer Rosen, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1174 Alturas Dr Unit 4b, Moscow, ID 83843 Phone: 360-828-8130 Fax: 360-785-2171 | |
Dr. William A. Cone, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 831 Ash St, Moscow, ID 83844 Phone: 208-885-9232 Fax: 208-885-6924 | |
Preetha S Rosen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 623 S Main St Ste 1, Moscow, ID 83843 Phone: 208-882-2011 | |
Barbara D Morgan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 S Washington, Suite 201, Moscow, ID 83843 Phone: 208-882-1777 Fax: 208-882-7006 | |
Dr. Elise June Augenstein, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 804 S Washington St, Suite A, Moscow, ID 83843 Phone: 208-883-6476 |